Vitamin K intake and hip fractures in women: A prospective study

American Journal of Clinical Nutrition

Volumn 69, Issue 1, 1999, Pages 74-79

  Feskanich, Diane ^a   Weber, Peter ^b   Willett, Walter C ^b   Rockett, Helaine ^b   Booth, Sarah L ^b   Colditz, Graham A ^b  

^a CHANNING LABORATORY   (United States)

^b NONE

Author keywords

Bone; Diet; Fractures; Hips; Nurses' Health Study; Osteoporosis; Phylloquinone; Undercarboxylated osteocalcin; Vitamin K; Women

Indexed keywords

OSTEOCALCIN; VITAMIN K GROUP;

ADULT; ARTICLE; DIETARY INTAKE; FEMALE; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; OSTEOPOROSIS; RISK; VEGETABLE; VITAMIN INTAKE;

LACTUCA;

EID: 0032919414     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/69.1.74     Document Type: Article

References (50)

1. Suttie JW. Vitamin K-dependent carboxylase. Annu Rev Biochem 1995;54:459-77.
2. Nelsestuen GL, Zytkovicz TH, Howard JB. The mode of action of vitamin K. Identification of γ-carboxyglutamic acid as a component of prothrombin. J Biol Chem 1974;249:6347-50.
3. Shearer MJ. Vitamin K. Lancet 1995;345:229-34.
4. National Research Council. Recommended dietary allowances. 10th ed. Washington, DC: National Academy Press, 1989.
5. Binkley NC, Suttie JW. Vitamin K nutrition and osteoporosis. J Nutr 1995;125:1812-21.
6. Vermeer C, Jie K-S G, Knapen MHJ. Role of vitamin K in bone metabolism. Annu Rev Nutr 1995;15:1-22.
7. Weber P. Management of osteoporosis: is there a role for vitamin K? Int J Vitam Nutr Res 1997;67:350-6.
8. Price PA. Role of vitamin K-dependent proteins in bone metabolism. Annu Rev Nutr 1988;8:565-83.
9. Sokoll LJ, Booth SL, O'Brien ME, Davidson KW, Tsaioun KI, Sadowski JA. Changes in serum osteocalcin, plasma phylloquinone, and urinary γ-carboxyglutamic acid in response to altered intakes of dietary phylloquinone in human subjects. Am J Clin Nutr 1997;65: 779-84.
10. Szulc P, Arlot M, Chapuy MC, Duboeuf F, Meunier PJ, Delmas PD. Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J Bone Miner Res 1994;9:1591-5.
11. Jie KSG, Bots ML, Vermeer C, Witteman JCM, Grobbee DR. Vitamin K status and bone mass in women with and without aortic atherosclerosis: a population-based study. Calcif Tissue Int 1996;59: 352-6.
12. Szulc P, Chapuy MC, Meunier PJ, Delmas PD. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 1993;91:1769-74.
13. Kohlmeier M, Saupe J, Shearer MJ, Schaefer K, Asmus G. Bone health of adult hemodialysis patients is related to vitamin K status. Kidney Int 1997;51:1218-21.
14. Vergnaud P, Garnero P, Meunier PJ, Breart G, Kamihagi K, Delmas PD. Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. J Clin Endocrinol Metab 1997;82:719-24.
15. Kon-Siong GJ, Hamulyak K, Gijsbers BL, Roumen FJ, Vermeer C. Effects of vitamin K and oral anticoagulants on urinary calcium excretion. Br J Haematol 1993;83:100-4.
16. Scholz-Ahrens KE, Bohme P, Schrezenmeir J, Milchforschung BF. Vitamin K deficiency affects calcium retention, bone mineralization and APb in growing and ovariectomized rats. Osteoporosis Int 1996; 6:S141 (abstr).
17. 2 (menatetrenon) inhibits prostaglandin synthesis in cultured human osteoblast-like periosteal cells by inhibiting prostaglandin H synthase activity. Biochem Pharmacol 1993;46:1355-62.
18. 2 synthesis in vitro. J Bone Miner Res 1993;8:535-42.
19. Reddi K, Henderson B, Meghji S, et al. Interleukin 6 production by lipopolysaccharide-stimulated human fibroblasts is potently inhibited by naphthoquinone (vitamin K) compounds. Cytokine 1995;7:287-90.
20. Kanai T, Takagi T, Masuhiro K, Nakamura M, Iwata M, Saji F. Serum vitamin K level and bone mineral density in postmenopausal women. Int J Gynecol Obstet 1997;56:25-30.
21. 1 in osteoporosis. J Clin Endocrinol Metab 1985;60:1268-9.
22. 2 decreased in elderly women with hip fracture. J Bone Miner Res 1993;8:1241-5.
23. Knapen MHJ, Hamulyak K, Vermeer C. The effect of vitamin K supplementation on circulating osteocalcin and urinary calcium excretion. Ann Intern Med 1989;111:1001-5.
24. Douglas AS, Robins SP, Hutchison JD, Porter RW, Stewart A, Reid DM. Carboxylation of osteocalcin in postmenopausal osteoporotic women following vitamin K and D supplementation. Bone 1995;17:15-20.
25. 3. J Bone Miner Res 1992;7:5122 (abstr).
26. Akjba T, Kurihara S, Tachibana K. Vitamin K increased bone mass in hemo-dialysis patients with low-turnover bone disease. J Am Soc Nephrol 1991;608:42P (abstr).
27. Rosen HN, Maitland LA, Suttie JW, Manning WJ, Glynn RJ, Greenspan SL. Vitamin K and maintenance of skeletal integrity in adults. Am J Med 1993;94:62-8.
28. Piro LD, Whyte MP, Murphy WA, Birge SJ. Normal cortical bone mass in patients after long term coumadin therapy. J Clin Endocrinol Metab 1982;54:470-3.
29. Resch J, Pietschmann P, Krexner E, Willvonseder R. Decreased peripheral bone mineral content in patients under anticoagulant therapy with phenprocoumon. Eur Heart J 1991;12:439-41.
30. Fiore CE, Tamburino C, Foti R, Grimaldi D. Reduced bone mineral content in patients taking an oral anticoagulant. South Med J 1990;83:538-42.
31. Philip WJ, Martin JC, Richardson JM, Reid DM, Webster J, Doublas AS. Decreased axial and peripheral bone density in patients taking long-term warfarin. Q J Med 1995;88:635-40.
32. Willett WC, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 1986;124:17-27.
33. 1 (phylloquinone) content of foods: a provisional table. J Food Comp Anal 1993;6:109-20.
34. 1) content of foods in the U.S. Food and Drug Administration's Total Diet Study. J Agric Food Chem 1995;43:1574-9.
35. 1) in various food matrices. J Agric Food Chem 1994;42:295-300.
36. Booth SL, Tucker KL, McKeown NM, Davidson KW, Dallal GE, Sadowski JA. Relationships between dietary intakes and fasting plasma concentrations of fat-soluble vitamins in humans. J Nutr 1997;127:587-92.
37. Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 1992;135:1114-26.
38. Feskanich D, Rimm EB, Giovannucci EL, et al. Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc 1993;93:790-6.
39. Colditz GA, Martin P, Stampfer MJ, et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol 1986;123:894-900.
40. Kleinbaum DG, Kupper LL, Morganstein H. Epidemiologic research: principles and quantitative methods. New York: Van Nostrand Reinhold Co, 1982.
41. Cox DR. Regression models and life-tables. J R Stat Soc 1972;34: 187-220.
42. Booth SL, Pennington JAT, Sadowski JA. Food sources and dietary intakes of vitamin K-1 (phylloquinone) in the American diet: data from the FDA Total Diet Study. J Am Diet Assoc 1996;96:149-54.
43. Jones DY, Koonsvitsky BP, Ebert ML, et al. Vitamin K status of free-living subjects consuming olestra. Am J Clin Nutr 1991;53: 943-6.
44. Booth SL, Sokoll LJ, O'Brien ME, Tucker K, Dawson-Hughes B, Sadowski JA. Assessment of dietary phylloquinone intake and vitamin K status in postmenopausal women. Eur J Clin Nutr 1995;49:832-41.
45. Deyl Z, Adam M. Evidence for vitamin D dependent γ-carboxylation in osteocalcin related proteins. Biochem Biophys Res Commun 1983;113:294-300.
46. 3 increases synthesis of the vitamin K-dependent bone protein by osteosarcoma cells. J Biol Chem 1980;255:11660-3.
47. Szulc P, Delmas PD. Influence of vitamin D and retinoids on the gammacarboxylation of osteocalcin in human osteosarcoma MG63 cells. Bone 1996;19:615-20.
48. Riggs BL, Jowsey J, Goldsmith RS, Kelly PJ, Hoffman DL, Arnaud CD. Short- and long-term effects of oestrogen and synthetic anabolic hormone in postmenopausal osteoporosis. J Clin Invest 1972;51:1659-63.
49. Eriksen E, Colvard D, Berg N, et al. Evidence of estrogen receptors in normal human osteoblast-line cells. Science 1988;241:84-7.
50. Miyaura C, Kasano K, Masuzawa T, et al. Endogenous bone-resorbing factors in estrogen deficiency: cooperative effects of IL-1 and IL-6. J Bone Miner Res 1995;10:1365-73.